secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001731122-25-000935
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex extends CEO Missling's term to 2028 with $800k salary; PFO receives indefinite term and increased severance
--------------------------------------------------------------------------------

- CEO Christopher Missling's employment term extended through July 5, 2028, with base salary $800,000 and target cash bonus of 20% of salary.
- PFO Sandra Boenisch's employment made indefinite; base salary set at CAD $279,840 with 20% target bonus.
- Boenisch's severance upon termination without cause increased from 6 to 12 months of base salary.
- Both amendments effective July 3, 2025; Missling's annual equity grant remains at Compensation Committee's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112225000935/0001731122-25-000935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112225000935/e6684_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer